What if we could increase productivity and stave the capital flight by helping Life Sciences startups build their companies more efficiently? We’re going to test this hypothesis by teaching a Lean LaunchPad class for Life Sciences and Health Care (therapeutics, diagnostics, devices and digital health) this October at UCSF with a team of veteran venture capitalists.
Part 1 of this post described the issues in the drug discovery. Part 2 covered medical devices and digital health. This post describes what we’re going to do about it. And why you ought to take this class. When I wrote Four Steps to the Epiphany and the Startup Owners Manual, I believed that Life Sciences startups didn’t need Customer Discovery. Heck how hard could it be? You invent a cure for cancer and then figure out where to put the bags of money. (In fact, for oncology, with a successful clinical trial, this is the case.)
What if we could increase productivity and stave the capital flight by helping Life Sciences startups build their companies more efficiently?
Since the 1990's, Steve Blank has been helping software companies all over the world innovate in how they build their companies. He's been doing this by teaching evidence based entrepreneurship, a framework where startups use hypotheses and experiments to validate their business models. We've been huge fans for a number of years and have applied many of his lessons to our company. Now over a series of posts, Steve has been outlining how to increase the success rate of life sciences startups. Over the next few weeks we'll be re-posting these here for you, with permission of course. Originally posted on August 19, 2013 by Steve Blank on steveblank.com